Novel mechanism of JNK pathway activation by adenoviral E1A

Oncotarget

Volumn 5, Issue 8, 2014, Pages 2176-2186

  Romanov, Vasily S ^a   Brichkina, Anna I ^a,b,d   Morrison, Helen ^a   Pospelova, Tatiana V ^b,c   Pospelov, Valery A ^b,c   Herrlich, Peter ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Adenoviral E1A; AP 1 subunit c jun; ERM family proteins; JNK signaling pathway; Small gtpase rac1

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; E1A PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; ESTROGEN RECEPTOR ALPHA; ONCOPROTEIN; SMALL INTERFERING RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; IN VITRO STUDY; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; 3T3 CELL LINE; ANIMAL; CELL LINE; GENETIC TRANSFECTION; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; MOUSE; PHYSIOLOGY; VIRUS CELL TRANSFORMATION;

ADENOVIRUS E1A PROTEINS; ANIMALS; CELL LINE; CELL TRANSFORMATION, VIRAL; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAP KINASE SIGNALING SYSTEM; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84899557696     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1860     Document Type: Article

References (67)

1. Turnell AS. (2008). Adenoviruses: Malignant Transformation and Oncology. In: Mahy BWJ and Regenmortel MHVv, eds. Encyclopedia of Virology (Third Edition). (Oxford: Academic Press), pp. 9-16.
2. Flint SJ, Sambrook J, Williams JF and Sharp PA. Viral nucleic acid sequences in transformed cells. IV. A study of the sequences of adenovirus 5 DNA and RNA in four lines of adenovirus 5-transformed rodent cells using specific fragments of the viral genome. Virology. 1976; 72(2):456-470.
3. Graham FL, Smiley J, Russell WC and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. The Journal of general virology. 1977; 36(1):59-74.
4. White E. Regulation of Apoptosis by Adenovirus E1A and E1B Oncogenes. Seminars in Virology. 1998; 8(6):505-513.
5. Lin HJ, Eviner V, Prendergast GC and White E. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Molecular and cellular biology. 1995; 15(8):4536-4544.
6. Ruley HE. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 1983; 304(5927):602-606.
7. Seger YR, Garcia-Cao M, Piccinin S, Cunsolo CL, Doglioni C, Blasco MA, Hannon GJ and Maestro R. Transformation of normal human cells in the absence of telomerase activation. Cancer cell. 2002; 2(5):401-413.
8. Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA and Pospelova TV. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Oncogene. 1999; 18(41):5611-5619.
9. Cha EJ, Oh BC, Wee HJ, Chi XZ, Goh YM, Lee KS, Ito Y and Bae SC. E1A physically interacts with RUNX3 and inhibits its transactivation activity. Journal of cellular biochemistry. 2008; 105(1):236-244.
10. Frisch SM and Mymryk JS. Adenovirus-5 E1A: paradox and paradigm. Nature reviews Molecular cell biology. 2002; 3(6):441-452.
11. Hagmeyer BM, Konig H, Herr I, Offringa R, Zantema A, van der Eb A, Herrlich P and Angel P. Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun. The EMBO journal. 1993; 12(9):3559-3572.
12. Duyndam MC, van Dam H, Smits PH, Verlaan M, van der Eb AJ and Zantema A. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A. Oncogene. 1999; 18(14):2311-2321.
13. Gupta S, Campbell D, Derijard B and Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 1995; 267(5196):389-393.
14. Livingstone C, Patel G and Jones N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. The EMBO journal. 1995; 14(8):1785-1797.
15. Kukushkin AN, Abramova MV, Svetlikova SB, Darieva ZA, Pospelova TV and Pospelov VA. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Oncogene. 2002; 21(5):719-730.
16. van Dam H, Huguier S, Kooistra K, Baguet J, Vial E, van der Eb AJ, Herrlich P, Angel P and Castellazzi M. Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes & development. 1998; 12(8):1227-1239.
17. Offringa R, Gebel S, van Dam H, Timmers M, Smits A, Zwart R, Stein B, Bos JL, van der Eb A and Herrlich P. A novel function of the transforming domain of E1a: repression of AP-1 activity. Cell. 1990; 62(3):527-538.
18. Karin M. The regulation of AP-1 activity by mitogenactivated protein kinases. The Journal of biological chemistry. 1995; 270(28):16483-16486.
19. D'Angelo R, Aresta S, Blangy A, Del Maestro L, Louvard D and Arpin M. Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoGdependent apical cytoskeleton rearrangements in epithelial cells. Molecular biology of the cell. 2007; 18(12):4780-4793.
20. Geissler KJ, Jung MJ, Riecken LB, Sperka T, Cui Y, Schacke S, Merkel U, Markwart R, Rubio I, Than ME, Breithaupt C, Peuker S, Seifert R, Kaupp UB, Herrlich P and Morrison H. Regulation of Son of sevenless by the membrane-actin linker protein ezrin. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(51):20587-20592.
21. Gloerich M, Ponsioen B, Vliem MJ, Zhang Z, Zhao J, Kooistra MR, Price LS, Ritsma L, Zwartkruis FJ, Rehmann H, Jalink K and Bos JL. Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. Molecular and cellular biology. 2010; 30(22):5421-5431.
22. Prag S, Parsons M, Keppler MD, Ameer-Beg SM, Barber P, Hunt J, Beavil AJ, Calvert R, Arpin M, Vojnovic B and Ng T. Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42. Molecular biology of the cell. 2007; 18(8):2935-2948.
23. Sperka T, Geissler KJ, Merkel U, Scholl I, Rubio I, Herrlich P and Morrison HL. Activation of Ras requires the ERMdependent link of actin to the plasma membrane. PloS one. 2011; 6(11):e27511.
24. Takahashi K, Sasaki T, Mammoto A, Hotta I, Takaishi K, Imamura H, Nakano K, Kodama A and Takai Y. Interaction of radixin with Rho small G protein GDP/GTP exchange protein Dbl. Oncogene. 1998; 16(25):3279-3284.
25. Takahashi K, Sasaki T, Mammoto A, Takaishi K, Kameyama T, Tsukita S and Takai Y. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/ moesin initiates the activation of the Rho small G protein. The Journal of biological chemistry. 1997; 272(37):23371-23375.
26. Egan C, Jelsma TN, Howe JA, Bayley ST, Ferguson B and Branton PE. Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Molecular and cellular biology. 1988; 8(9):3955-3959.
27. Mymryk JS, Lee RW and Bayley ST. Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Molecular biology of the cell. 1992; 3(10):1107-1115.
28. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103(2):239-252.
29. Bishop AL and Hall A. Rho GTPases and their effector proteins. The Biochemical journal. 2000; 348 Pt 2:241-255.
30. Cherfils J and Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiological reviews. 2013; 93(1):269-309.
31. Kitabayashi I, Eckner R, Arany Z, Chiu R, Gachelin G, Livingston DM and Yokoyama KK. Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. The EMBO journal. 1995; 14(14):3496-3509.
32. Kolli S, Buchmann AM, Williams J, Weitzman S and Thimmapaya B. Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(8):4646-4651.
33. Missero C, Filvaroff E and Dotto GP. Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins. Proceedings of the National Academy of Sciences of the United States of America. 1991; 88(8):3489-3493.
34. Malliri A, van Es S, Huveneers S and Collard JG. The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions. The Journal of biological chemistry. 2004; 279(29):30092-30098.
35. Adams DR, Ron D and Kiely PA. RACK1, A multifaceted scaffolding protein: Structure and function. Cell communication and signaling : CCS. 2011; 9:22.
36. Mamidipudi V, Zhang J, Lee KC and Cartwright CA. RACK1 regulates G1/S progression by suppressing Src kinase activity. Molecular and cellular biology. 2004; 24(15):6788-6798.
37. Wang F, Yamauchi M, Muramatsu M, Osawa T, Tsuchida R and Shibuya M. RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway. The Journal of biological chemistry. 2011; 286(11):9097-9106.
38. Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin J, Lv M, Li X, Li Y, Ma Y, Shen B and Zhang J. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity. Hepatology. 2013; 57(1):140-151.
39. Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH and Ronai Z. RACK1 mediates activation of JNK by protein kinase C [corrected]. Molecular cell. 2005; 19(3):309-320.
40. Severino A, Baldi A, Cottone G, Han M, Sang N, Giordano A, Mileo AM, Paggi MG and De Luca A. RACK1 is a functional target of the E1A oncoprotein. Journal of cellular physiology. 2004; 199(1):134-139.
41. Ivetic A and Ridley AJ. Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology. 2004; 112(2):165-176.
42. Jiang H, Olson MV, Medrano DR, Lee OH, Xu J, Piao Y, Alonso MM, Gomez-Manzano C, Hung MC, Yung WK and Fueyo J. A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2006; 20(14):2603-2605.
43. Douglas JL and Quinlan MP. Structural limitations of the Ad5 E1A 12S nuclear localization signal. Virology. 1996; 220(2):339-349.
44. Fax P, Carlson CR, Collas P, Tasken K, Esche H and Brockmann D. Binding of PKA-RIIalpha to the Adenovirus E1A12S oncoprotein correlates with its nuclear translocation and an increase in PKA-dependent promoter activity. Virology. 2001; 285(1):30-41.
45. Turnell AS, Grand RJ, Gorbea C, Zhang X, Wang W, Mymryk JS and Gallimore PH. Regulation of the 26S proteasome by adenovirus E1A. The EMBO journal. 2000; 19(17):4759-4773.
46. Zaremba A, Schmuecker U and Esche H. Sprouty is a cytoplasmic target of adenoviral E1A oncoproteins to regulate the receptor tyrosine kinase signalling pathway. Virology journal. 2011; 8:192.
47. van Dam H, Duyndam M, Rottier R, Bosch A, de Vries-Smits L, Herrlich P, Zantema A, Angel P and van der Eb AJ. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. The EMBO journal. 1993; 12(2):479-487.
48. Vandel L, Montreau N, Vial E, Pfarr CM, Binetruy B and Castellazzi M. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization. Molecular and cellular biology. 1996; 16(5):1881-1888.
49. Behrens A, Jochum W, Sibilia M and Wagner EF. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene. 2000; 19(22):2657-2663.
50. Engelberg D. Stress-activated protein kinases-tumor suppressors or tumor initiators? Seminars in cancer biology. 2004; 14(4):271-282.
51. Sabapathy K. Role of the JNK pathway in human diseases. Progress in molecular biology and translational science. 2012; 106:145-169.
52. Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P, Jacks T and Davis RJ. Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Molecular and cellular biology. 2011; 31(7):1565-1576.
53. Chen N, Nomura M, She QB, Ma WY, Bode AM, Wang L, Flavell RA and Dong Z. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer research. 2001; 61(10):3908-3912.
54. Dhanasekaran DN and Reddy EP. JNK signaling in apoptosis. Oncogene. 2008; 27(48):6245-6251.
55. Shaulian E and Karin M. AP-1 as a regulator of cell life and death. Nature cell biology. 2002; 4(5):E131-136.
56. Heasley LE and Han SY. JNK regulation of oncogenesis. Molecules and cells. 2006; 21(2):167-173.
57. Kennedy NJ and Davis RJ. Role of JNK in tumor development. Cell cycle. 2003; 2(3):199-201.
58. Kennedy NJ, Sluss HK, Jones SN, Bar-Sagi D, Flavell RA and Davis RJ. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes & development. 2003; 17(5):629-637.
59. Eferl R and Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nature reviews Cancer. 2003; 3(11):859-868.
60. Hess J, Angel P and Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. Journal of cell science. 2004; 117(Pt 25):5965-5973.
61. Buchou T, Kranenburg O, van Dam H, Roelen D, Zantema A, Hall FL and van der Eb A. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines. Oncogene. 1993; 8(7):1765-1773.
62. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes & development. 1998; 12(15):2434-2442.
63. Jelsma TN, Howe JA, Mymryk JS, Evelegh CM, Cunniff NF and Bayley ST. Sequences in E1A proteins of human adenovirus 5 required for cell transformation, repression of a transcriptional enhancer, and induction of proliferating cell nuclear antigen. Virology. 1989; 171(1):120-130.
64. Rasti M, Grand RJ, Mymryk JS, Gallimore PH and Turnell AS. Recruitment of CBP/p300, TATA-binding protein, and S8 to distinct regions at the N terminus of adenovirus E1A. Journal of virology. 2005; 79(9):5594-5605.
65. Kumar V, Green S, Staub A and Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. The EMBO journal. 1986; 5(9):2231-2236.
66. Gedrich RW, Bayley ST and Engel DA. Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. Journal of virology. 1992; 66(10):5849-5859.
67. Weg-Remers S, Ponta H, Herrlich P and Konig H. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. The EMBO journal. 2001; 20(15):4194-4203.